In 2016, Maurer et al. [8] were the first to publish their results comparing 68Ga-PSMA-PET with CT and mpMRI in 130 patients with intermediate- to high-risk PCa scheduled for RP and ePLND. This evidence concerns the gene FOLH1 and posterior cortical atrophy.